These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27769108)

  • 1. Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease.
    Mobarak L; Omran D; Nabeel MM; Zakaria Z
    J Med Virol; 2017 Jun; 89(6):1062-1068. PubMed ID: 27769108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular Carcinoma Multidisciplinary Clinic-Cairo University (HMC-CU) score: A new simple score for diagnosis of HCC.
    Abdelaziz AO; Nabil MM; Omran DA; Abdelmaksoud AH; Asem N; Shousha HI; Elbaz TM; Leithy R
    Arab J Gastroenterol; 2020 Jun; 21(2):102-105. PubMed ID: 32439235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.
    Li X; Xu H; Gao P
    Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis.
    Sahin T; Serin A; Emek E; Bozkurt B; Arikan BT; Tokat Y
    Transplant Proc; 2019 Sep; 51(7):2397-2402. PubMed ID: 31402255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.
    Yosry A; Fouad R; Alem SA; Elsharkawy A; El-Sayed M; Asem N; Hassan E; Ismail A; Esmat G
    Arab J Gastroenterol; 2016 Jun; 17(2):78-83. PubMed ID: 27353055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibro-indices versus liver stiffness for prediction of significant fibrosis in hepatitis B virus-infected Egyptian patients; a single-center experience.
    Said M; Eletreby R; Omar H; Dabees H; Abdelghafour R; El-Serafy M; Doss W
    Expert Rev Gastroenterol Hepatol; 2020 Mar; 14(3):221-227. PubMed ID: 32031424
    [No Abstract]   [Full Text] [Related]  

  • 10. Development and evaluation of a novel score for prediction of large oesophageal varices in patients with hepatitis c virus-induced liver cirrhosis.
    Farid K; Omran MM; Farag RE; Arafa MM; Emran TM
    Br J Biomed Sci; 2017 Jul; 74(3):138-143. PubMed ID: 28504002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients.
    Abdelgawad IA
    J Clin Pathol; 2015 Feb; 68(2):154-60. PubMed ID: 25430496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
    Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
    World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores: How Much Do Routine Blood Tests Tell About Liver Fibrosis in Chronic Hepatitis C?
    Thandassery RB; Al Kaabi S; Soofi ME; Mohiuddin SA; John AK; Al Mohannadi M; Al Ejji K; Yakoob R; Derbala MF; Wani H; Sharma M; Al Dweik N; Butt MT; Kamel YM; Sultan K; Pasic F; Singh R
    J Clin Gastroenterol; 2016 Jul; 50(6):518-23. PubMed ID: 26974762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fibrosis indices for identifying patients at low risk of developing hepatocellular carcinoma after eradication of HCV.
    Toyoda H; Tada T; Tachi Y; Hirai T; Yasuda S; Honda T; Hayashi K; Ishigami M; Goto H; Kumada T
    Antivir Ther; 2017; 22(3):185-193. PubMed ID: 27586087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.
    Göbel T; Vorderwülbecke S; Hauck K; Fey H; Häussinger D; Erhardt A
    World J Gastroenterol; 2006 Dec; 12(47):7604-12. PubMed ID: 17171788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B: liver fibrosis and hepatocellular carcinoma.
    Lok AS
    Gastroenterol Clin Biol; 2009; 33(10-11):911-5. PubMed ID: 19577871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.
    Abdelaziz AO; Shousha HI; Said EM; Soliman ZA; Shehata AA; Nabil MM; Abdelmaksoud AH; Elbaz TM; Abdelsalam FM
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1384-1388. PubMed ID: 30179227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.